DROSHA and myelodysplastic syndrome: In a first study, the targeted deletion of the Dicer I, ribonuclease III (Dicer I), in a well-defined population of mesenchymal progenitors recapitulates features of human myelodysplastic syndrome (MDS), including the propensity to develop into AML (73).